Vaccine Therapy for Patients With Stage IV Melanoma

NCT00052156 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

670

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Melanoma

Interventions

BIOLOGICAL: CancerVax vaccine (CANVAXIN)

Sponsor

CancerVax Corporation